- Statement Regarding Illumina’s Decision to Divest Grail ( )
- Statement Regarding the Termination of John Muir’s Takeover of San Ramon Regional Medical Center from Tenet Healthcare ( )
- Federal Trade Commission and Justice Department Release 2023 Merger Guidelines ( )
- FTC Approves Final Order Settling Horizon Therapeutics Acquisition Challenge ( )
- Statement Regarding the Termination of Sanofi’s Proposed Acquisition of Maze Therapeutics’ Pompe Disease Drug ( )
- FTC Seeks to Block Sanofi’s Acquisition of Rare Disease Drug that Threatens Sanofi’s Monopoly ( )
- FTC Sues 7-Eleven for Anticompetitive Acquisition in Violation of 2018 Consent Order ( )
- FTC Sues to Block John Muir Health’s Takeover of San Ramon Regional Medical Center ( )
- FTC Approves Final Order Resolving Antitrust Concerns Surrounding ICE, Black Knight Deal ( )
- FTC and DOJ to Co-Host November 3 Workshop on the 2023 Draft Merger Guidelines ( )
- FTC Approves Final Order to Prevent Interlocking Directorate Arrangement, Anticompetitive Information Exchange in EQT, Quantum Energy Deal ( )
- FTC and DOJ to Co-Host October 5 Workshop on the 2023 Draft Merger Guidelines ( )
- FTC and DOJ Announce Additional Workshops on the 2023 Draft Merger Guidelines ( )
- Biopharmaceutical Giant Amgen to Settle FTC and State Challenges to its Horizon Therapeutics Acquisition ( )
- FTC and DOJ to Co-Host 2023 Draft Merger Guidelines Workshop on September 5 ( )
- FTC Secures Settlement with ICE and Black Knight Resolving Antitrust Concerns in Mortgage Technology Deal ( )
- FTC and DOJ Announce Workshops on the 2023 Draft Merger Guidelines ( )
- FTC Acts to Prevent Interlocking Directorate Arrangement, Anticompetitive Information Exchange in EQT, Quantum Energy Deal ( )
- FTC and DOJ Extend Public Comment Period by 30 Days on Proposed Changes to HSR Form ( )
- Statement Regarding Termination of CooperCompanies’ Attempted Acquisition of Cook Medical’s Reproductive Health Business ( )
- FTC and DOJ Seek Comment on Draft Merger Guidelines ( )
- FTC Sues to Block IQVIA’s Acquisition of Propel Media to Prevent Increased Concentration in Health Care Programmatic Advertising ( )
- FTC and DOJ Propose Changes to HSR Form for More Effective, Efficient Merger Review ( )
- FTC Policy Director Issues Statement Commending Maine’s Repeal of Certificate of Public Advantage Law ( )
- FTC Staff Opposes State Legislation in North Carolina Designed to Shield UNC Health System from Antitrust Enforcement ( )
- FTC, DOJ Issue Summary on Joint Pharmaceutical Merger Analysis Workshop ( )
- Statement Regarding the Termination of Boston Scientific Corporation’s Attempted Acquisition of a Majority Stake in M.I. Tech Co., Ltd. ( )
- FTC Sues to Block Biopharmaceutical Giant Amgen from Acquisition That Would Entrench Monopoly Drugs Used to Treat Two Serious Illnesses ( )
- Statement Regarding the Termination of CalPortland Company’s Attempted Acquisition of Assets Owned by Rival Cement Producer Martin Marietta Materials, Inc. ( )
- FTC Sues to Stop the Potentially Illegal Integration of New Orleans Area Hospitals Over Failure to Follow Federal Reporting Law ( )
El .gov significa que es oficial.
Los sitios web del gobierno federal siempre usan un dominio .gov o .mil. Antes de compartir información confidencial en línea, asegúrese de estar en un sitio .gov o .mil.
Este sitio es seguro.
El https:// medios todos los datos transmitidos son cifrados - en otras palabras, cualquier información o el historial de navegación que proporcione se transmite de forma segura.